Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-03

FDA Approved: IRBESARTAN — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approves the original ANDA for irbesartan (IRBESARTAN) from NorthStar RxLLC as a generic version of the hypertension medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)